ALDOA and Alzheimer disease: While overlapping pathology between AD and other groups suggested ALDOA was a non-specific biomarker for AD and thus a poor candidate for immunotherapy 37,39, the utility of ALDOA as a biomarker for stratification within defined AD patients has not been fully explored.